Reimagining Agentic AI in Healthcare

 

Ganesh Padmanabhan, the CEO and Co-Founder of Autonomize AI, a pioneering company enabling knowledge workers in regulated industries to have access to trusted, safe AI solutions joins eHealth Radio and the Healthcare and Technology Channels.

Listen to interview with host Eric Michaels & guest Ganesh Padmanabhan discuss the following:

1. What is Autonomize AI, and the value it brings to different healthcare stakeholders?
2. Give us a working definition of the term Agentic AI—and a few of the biggest improvements/use cases it will bring to healthcare?
3. Let's talk about the challenges and opportunies around data in healthcare: First, what type of size and challenges are we dealing with? What is 'unstructured data', and the challenges that it brings? And what are the opportunities and possibilities to meaningful transform our health system?
4. Autonomize has an important differentiator called "Compound AI”  i What does this mean? Walk us through a real example of how these specialized agents collaborate to solve a complex administrative challenge that’s impacting healthcare organizations and patients?
5. Ganesh, one of the areas you're most passionate about is what you call the AI-driven Enterprise. Paint a picture for how you see this evolving and integrating into healthcare, and what impact do you see it having on healthcare organizations, patients, and the system as a whole?
6. How can our listeners learn more about what Autonomize AI is doing, and how it can help.

Ganesh Padmanabhan is the CEO and co-founder of Autonomize AI, a pioneering company enabling knowledge workers in regulated industries to have access to trusted, safe AI solutions. Under his leadership, Autonomize develops AI copilots that organize, contextualize, and summarize unstructured healthcare data, reducing administrative burden while enabling data-driven decisions that improve patient outcomes.

A visionary in healthcare AI, Ganesh founded Autonomize AI in January 2022 after successful ventures in explainable AI and data aggregation. The company serves an impressive roster of clients including Top 20 pharmaceutical companies, Fortune 100 payers, and leading value-based care organizations. Autonomize AI is also a founding member of CancerX, part of the U.S. President's Cancer Moonshot initiative.

With over 20 years of experience in technology and artificial intelligence, Ganesh brings deep expertise in leveraging AI to unlock value from clinical and biomedical data. He is committed to developing patient-centric innovations that prioritize data privacy and ethical AI practices. His vision centers on making AI a catalyst for extending human cognition in healthcare, enabling organizations and individuals to reach their maximum potential.

Beyond Autonomize, Ganesh founded Stories in AI, a podcast and edutainment platform exploring AI's transformative impact through storytelling. His extensive career includes scaling venture-backed AI companies like Molecula and CognitiveScale, as well as leading growth initiatives during a 15-year tenure at Dell Technologies and Intel Corporation.

Ganesh is an active investor and advisor for multiple startups and serves as a mentor in Austin's entrepreneurial ecosystem. In 2020, he served on Texas Governor Greg Abbott's COVID-19 Strike Force on Innovation, helping leverage data for pandemic response decision-making.

A sought-after keynote speaker, Ganesh has been featured in Forbes, Business Insider, Fast Company, and other leading publications. He was recognized by Enterprise Management 360 as one of the 10 tech experts revolutionizing AI in 2018.

Ganesh holds a bachelor's degree in Mechanical Engineering from the University of Calicut, India, and an MBA from the McCombs School of Business at the University of Texas at Austin.

Website: https://autonomize.ai

Social Media Links:
X: https://x.com/AutonomizeAI
Linkedin: https://www.linkedin.com/company/autonomizeai

People also listened to this: A Discussion of Stress Management Strategies for National Stress Awareness Month with Dr. Anna Levy-Warren